[CLINICAL TRIALS OF TRIETHYLENEIMINOBENZOQUINONE (TRENIMON)].
D000230:Adenocarcinoma; D000235:Adenolymphoma; D000293:Adolescent; D000970:Antineoplastic Agents; D001984:Bronchial Neoplasms; D005853:Geriatrics; D006689:Hodgkin Disease; D007680:Kidney Neoplasms; D008175:Lung Neoplasms; D016403:Lymphoma, Large B-Cell, Diffuse; D008228:Lymphoma, Non-Hodgkin; D009369:Neoplasms; D012516:Osteosarcoma; D012509:Sarcoma; D014228:Triaziquone
D000970:Antineoplastic Agents; D014228:Triaziquone
ADENOCARCINOMA; ADENOLYMPHOMA; ADOLESCENCE; ANTINEOPLASTIC AGENTS; BRONCHIAL NEOPLASMS; GERIATRICS; HODGKIN'S DISEASE; KIDNEY NEOPLASMS; LUNG NEOPLASMS; SARCOMA, OSTEOGENIC; SARCOMA, RETICULUM CELL
KLINISCHE ERFAHRUNGEN MIT TRISAETHYLENIMINOBENZOCHINON (TRENIMON